Parvovirus B19 - Revision history

Neil.m.young: Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-24T10:59:17Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Older revision		Revision as of 10:59, 24 July 2016
Line 19:		Line 19:
	*Group A Streptococcal infections		*Group A Streptococcal infections

	==~~Diagnosis~~==		==Evaluation==
	*Diagnosis is clinical usually through clinical presentation		*Diagnosis is clinical usually through clinical presentation
	*IgM testing is recommended for immunocompromised patients.		*IgM testing is recommended for immunocompromised patients.

2016-03-01T17:08:58Z

Clinical Features

2016-02-29T12:39:22Z

added clinical features

← Older revision		Revision as of 12:39, 29 February 2016
Line 7:		Line 7:
	==Clinical Features==		==Clinical Features==
	*[[Erythema infectiosum (fifth disease)]]		*[[Erythema infectiosum (fifth disease)]]
			*Most contagious during the phase of active viral replication and viral shedding, which occurs approximately 5 to 10 days after exposure and usually lasts approximately 5 days
	*Complications		*Complications
	**Arthropathy		**Arthropathy

2016-02-29T12:36:23Z

added ddx

← Older revision		Revision as of 12:36, 29 February 2016
Line 12:		Line 12:

	==Differential Diagnosis==		==Differential Diagnosis==
			*[[Roseola]]
			*[[Measles]]
			*[[Rubella]]
			*Enteroviral infections
			*Group A Streptococcal infections

	==Diagnosis==		==Diagnosis==

2016-02-29T12:34:01Z

edited diagnosis, management

← Older revision		Revision as of 12:34, 29 February 2016
Line 14:		Line 14:

	==Diagnosis==		==Diagnosis==
			*Diagnosis is clinical usually through clinical presentation
			*IgM testing is recommended for immunocompromised patients.

	==Management==		==Management==

2016-02-29T12:33:19Z

Clinical Features

← Older revision		Revision as of 12:33, 29 February 2016
Line 7:		Line 7:
	==Clinical Features==		==Clinical Features==
	*[[Erythema infectiosum (fifth disease)]]		*[[Erythema infectiosum (fifth disease)]]
	*[[Anemia]]		*Complications
			**Arthropathy
			**[[Aplastic Anemia]]

	==Differential Diagnosis==		==Differential Diagnosis==

2016-02-29T12:32:16Z

Management

← Older revision		Revision as of 12:32, 29 February 2016
Line 15:		Line 15:
	==Management==		==Management==
	*Parvovirus is usually self-limiting and requires no further treatment.		*Parvovirus is usually self-limiting and requires no further treatment.
			*Management should be targeted at reducing symptoms, such as using anti-inflammatory medications for arthropathy or performing transfusions for aplastic anemia.

	==Disposition==		==Disposition==

2016-02-29T12:31:35Z

added management

← Older revision		Revision as of 12:31, 29 February 2016
Line 14:		Line 14:

	==Management==		==Management==
			*Parvovirus is usually self-limiting and requires no further treatment.

	==Disposition==		==Disposition==

2016-02-07T12:45:51Z

← Older revision		Revision as of 12:45, 7 February 2016
Line 25:		Line 25:
	*Place R, Lagoc AT, Mayer TA, Lawlor CJ. Oncology and Hematology Emergencies in Children. In: Tintinalli JE, Stapczynski J, Ma O, Cline DM, Cydulka RK, Meckler GD, T. eds. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. New York, NY: McGraw-Hill; 2011		*Place R, Lagoc AT, Mayer TA, Lawlor CJ. Oncology and Hematology Emergencies in Children. In: Tintinalli JE, Stapczynski J, Ma O, Cline DM, Cydulka RK, Meckler GD, T. eds. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. New York, NY: McGraw-Hill; 2011
	<references/>		<references/>

			[[Category:ID]]

2016-02-07T12:45:09Z

Background

← Older revision		Revision as of 12:45, 7 February 2016
Line 1:		Line 1:
	==Background==		==Background==
	*In children: causes [[~~erythema infectiousum~~]] (Fifth disease)		*In children: causes [[Erythema infectiosum]] (Fifth disease)
	*In transplant patients on immunosuppressive drugs: causes RBC aplasia.		*In transplant patients on immunosuppressive drugs: causes RBC aplasia.
	**Short-lived, may not be discovered		**Short-lived, may not be discovered